- Home
- SYTA vs TTNP Comparison
SYTA vs TTNP Comparison
Compare SYTA & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- TTNP
- Stock Information
- Founded
- SYTA N/A
- TTNP 1991
- Country
- SYTA Canada
- TTNP United States
- Employees
- SYTA N/A
- TTNP N/A
- Industry
- SYTA Telecommunications Equipment
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SYTA Telecommunications
- TTNP Health Care
- Exchange
- SYTA Nasdaq
- TTNP Nasdaq
- Market Cap
- SYTA 3.1M
- TTNP 3.4M
- IPO Year
- SYTA 2020
- TTNP 1996
- Fundamental
- Price
- SYTA $2.31
- TTNP $4.67
- Analyst Decision
- SYTA
- TTNP
- Analyst Count
- SYTA 0
- TTNP 0
- Target Price
- SYTA N/A
- TTNP N/A
- AVG Volume (30 Days)
- SYTA 9.5M
- TTNP 42.9K
- Earning Date
- SYTA 05-27-2025
- TTNP 05-27-2025
- Dividend Yield
- SYTA N/A
- TTNP N/A
- EPS Growth
- SYTA N/A
- TTNP N/A
- EPS
- SYTA N/A
- TTNP N/A
- Revenue
- SYTA $11,740,024.00
- TTNP N/A
- Revenue This Year
- SYTA $14.02
- TTNP N/A
- Revenue Next Year
- SYTA N/A
- TTNP N/A
- P/E Ratio
- SYTA N/A
- TTNP N/A
- Revenue Growth
- SYTA 41.25
- TTNP N/A
- 52 Week Low
- SYTA $1.00
- TTNP $3.03
- 52 Week High
- SYTA $885.60
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- SYTA 66.79
- TTNP 57.83
- Support Level
- SYTA $1.10
- TTNP $4.52
- Resistance Level
- SYTA $2.00
- TTNP $5.10
- Average True Range (ATR)
- SYTA 0.30
- TTNP 0.50
- MACD
- SYTA 0.13
- TTNP 0.07
- Stochastic Oscillator
- SYTA 60.79
- TTNP 49.77
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.